Metraipolis › archive › dc_e9852db0e72b
Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer — Europe PMC PMID:42313870
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42313870
- DOI
- 10.1371/journal.pbio.3003860
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T08:29:13.069Z
- SHA-256 of the archived text
3a4a46d3246b2362e6facd8ea372554ae1e73079e44d2d6ed7b37572172f7f5f- Stable URL of this page
https://metraipolis.com/documento/dc_e9852db0e72b
How to cite
Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer — Europe PMC PMID:42313870 — Europe PMC (en), https://europepmc.org/article/MED/42313870 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e9852db0e72b (Metraipolis archive dc_e9852db0e72b, sha256 3a4a46d3246b2362e6facd8ea372554ae1e73079e44d2d6ed7b37572172f7f5f)
BibTeX
@misc{dce9852db0e72b,
title = {Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer — Europe PMC PMID:42313870},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42313870},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e9852db0e72b; sha256 3a4a46d3246b2362e6facd8ea372554ae1e73079e44d2d6ed7b37572172f7f5f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42313870. Agents can read the archived copy with the MCP tool read_document.